Jesper Høiland has served as our President and Chief Executive Officer since July 2017. Mr. Høiland has 30 years of experience in the biopharmaceutical industry across numerous senior leadership roles, geographies and therapeutic areas. He brings extensive knowledge about the areas of endocrinology, biopharmaceuticals and women’s health as well as unique insights about US market access. Prior to joining Radius, Mr. Høiland served as President/EVP of Novo Nordisk Inc. USA overseeing approximately 5,300 employees. Under his leadership, Novo Nordisk solidified its market leadership and growth in diabetes and also drove significant growth in its hemophilia and growth hormone franchises. Since joining Novo Nordisk in 1987, Mr. Høiland held multiple global roles of increasing responsibility, including leading its International Operations which spanned 150 countries. Mr. Høiland is a member of the board of directors of LEO Pharma, Concert Pharmaceuticals Inc., and is a frequent speaker at Wharton (University of Pennsylvania) and MIT Sloan. Mr. Høiland received his M.Sc. in Management from Copenhagen Business School in Denmark.